Roche Finance Ltd 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,334,113 4.400% |
-253,641 (-9.80%) |
Filing |
| 2021-02-16 07:02 am Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,587,754 5.100% |
2,587,754 (New Position) |
Filing |